315 related articles for article (PubMed ID: 35317838)
21. Chemerin-9, a potent agonist of chemerin receptor (ChemR23), prevents atherogenesis.
Sato K; Yoshizawa H; Seki T; Shirai R; Yamashita T; Okano T; Shibata K; Wakamatsu MJ; Mori Y; Morita T; Matsuyama TA; Ishibashi-Ueda H; Hirano T; Watanabe T
Clin Sci (Lond); 2019 Aug; 133(16):1779-1796. PubMed ID: 31399499
[TBL] [Abstract][Full Text] [Related]
22. Chemerin Regulates Crosstalk Between Adipocytes and Vascular Cells Through Nox.
Neves KB; Nguyen Dinh Cat A; Lopes RA; Rios FJ; Anagnostopoulou A; Lobato NS; de Oliveira AM; Tostes RC; Montezano AC; Touyz RM
Hypertension; 2015 Sep; 66(3):657-66. PubMed ID: 26150435
[TBL] [Abstract][Full Text] [Related]
23. Rosiglitazone ameliorates diabetic nephropathy by reducing the expression of Chemerin and ChemR23 in the kidney of streptozotocin-induced diabetic rats.
Hu W; Yu Q; Zhang J; Liu D
Inflammation; 2012 Aug; 35(4):1287-93. PubMed ID: 22350950
[TBL] [Abstract][Full Text] [Related]
24. Chemerin/ChemR23 axis triggers an inflammatory response in keratinocytes through ROS-sirt1-NF-κB signaling.
Wang Y; Huo J; Zhang D; Hu G; Zhang Y
J Cell Biochem; 2019 Apr; 120(4):6459-6470. PubMed ID: 30426542
[TBL] [Abstract][Full Text] [Related]
25. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism.
Goralski KB; McCarthy TC; Hanniman EA; Zabel BA; Butcher EC; Parlee SD; Muruganandan S; Sinal CJ
J Biol Chem; 2007 Sep; 282(38):28175-88. PubMed ID: 17635925
[TBL] [Abstract][Full Text] [Related]
26. Increased levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to inflammation: tumor necrosis factor-α stimulates mRNA levels of chemerin in visceral adipocytes from obese patients.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Rotellar F; Valentí V; Silva C; Gil MJ; Salvador J; Frühbeck G
Surg Obes Relat Dis; 2013; 9(2):306-14. PubMed ID: 22154272
[TBL] [Abstract][Full Text] [Related]
27. Chemerin promotes microangiopathy in diabetic retinopathy via activation of ChemR23 in rat primary microvascular endothelial cells.
Jun L; Lin-Lin S; Hui S
Mol Vis; 2021; 27():575-587. PubMed ID: 34531648
[TBL] [Abstract][Full Text] [Related]
28. Chemerin is a novel adipokine associated with obesity and metabolic syndrome.
Bozaoglu K; Bolton K; McMillan J; Zimmet P; Jowett J; Collier G; Walder K; Segal D
Endocrinology; 2007 Oct; 148(10):4687-94. PubMed ID: 17640997
[TBL] [Abstract][Full Text] [Related]
29. Chemerin as an Inducer of β Cell Proliferation Mediates Mitochondrial Homeostasis and Promotes β Cell Mass Expansion.
Li M; Zhang R; Ge Q; Yue L; Ma D; Khattab F; Xie W; Cui Y; Gilon P; Zhao X; Li X; Cheng R
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298086
[TBL] [Abstract][Full Text] [Related]
30. Chemerin in human cardiovascular disease.
Kaur J; Mattu HS; Chatha K; Randeva HS
Vascul Pharmacol; 2018 Nov; 110():1-6. PubMed ID: 30016719
[TBL] [Abstract][Full Text] [Related]
31. The chemerin/ChemR23 system does not affect the pro-inflammatory response of mouse and human macrophages ex vivo.
Bondue B; De Henau O; Luangsay S; Devosse T; de Nadaï P; Springael JY; Parmentier M; Vosters O
PLoS One; 2012; 7(6):e40043. PubMed ID: 22768214
[TBL] [Abstract][Full Text] [Related]
32. [Research progress of chemerin in polycystic ovary syndrome].
Zhu XJ; Qiu H; Liu SL; Dai W; Hu HB; Huang H
Sheng Li Xue Bao; 2024 Jun; 76(3):429-437. PubMed ID: 38939937
[TBL] [Abstract][Full Text] [Related]
33. Development by Genetic Immunization of Monovalent Antibodies (Nanobodies) Behaving as Antagonists of the Human ChemR23 Receptor.
Peyrassol X; Laeremans T; Gouwy M; Lahura V; Debulpaep M; Van Damme J; Steyaert J; Parmentier M; Langer I
J Immunol; 2016 Mar; 196(6):2893-901. PubMed ID: 26864035
[TBL] [Abstract][Full Text] [Related]
34. Chemerin/ChemR23 regulates cementoblast function and tooth resorption in mice via inflammatory factors.
Ye Y; Fang L; Li J; Wu H; Tan X; Luo H; Li X; Huang L
J Periodontol; 2021 Oct; 92(10):1470-1482. PubMed ID: 33289084
[TBL] [Abstract][Full Text] [Related]
35. Synthetic chemerin-derived peptides suppress inflammation through ChemR23.
Cash JL; Hart R; Russ A; Dixon JP; Colledge WH; Doran J; Hendrick AG; Carlton MB; Greaves DR
J Exp Med; 2008 Apr; 205(4):767-75. PubMed ID: 18391062
[TBL] [Abstract][Full Text] [Related]
36. Chemerin inhibits vascular calcification through ChemR23 and is associated with lower coronary calcium in chronic kidney disease.
Carracedo M; Witasp A; Qureshi AR; Laguna-Fernandez A; Brismar T; Stenvinkel P; Bäck M
J Intern Med; 2019 Oct; 286(4):449-457. PubMed ID: 31197872
[TBL] [Abstract][Full Text] [Related]
37. Chemerin: a multifaceted adipokine involved in metabolic disorders.
Helfer G; Wu QF
J Endocrinol; 2018 Aug; 238(2):R79-R94. PubMed ID: 29848608
[TBL] [Abstract][Full Text] [Related]
38. ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages.
Herová M; Schmid M; Gemperle C; Hersberger M
J Immunol; 2015 Mar; 194(5):2330-7. PubMed ID: 25637017
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of chemerin in squamous esophageal cancer myofibroblasts and role in recruitment of mesenchymal stromal cells.
Kumar JD; Holmberg C; Kandola S; Steele I; Hegyi P; Tiszlavicz L; Jenkins R; Beynon RJ; Peeney D; Giger OT; Alqahtani A; Wang TC; Charvat TT; Penfold M; Dockray GJ; Varro A
PLoS One; 2014; 9(7):e104877. PubMed ID: 25127029
[TBL] [Abstract][Full Text] [Related]
40. Chemerin-ChemR23 signaling in tooth development.
Ohira T; Spear D; Azimi N; Andreeva V; Yelick PC
J Dent Res; 2012 Dec; 91(12):1147-53. PubMed ID: 23053848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
